Market Cap ₹128 Cr.
Stock P/E 24.4
P/B 3.8
Current Price ₹214.8
Book Value ₹ 57.1
Face Value 10
52W High ₹325
Dividend Yield 0%
52W Low ₹ 80
Nirman Agri Genetics Limited (NAGL) is a public company that provides agri-input products and services in India. Incorporated in 2020, it has a focus on research and development, production, processing, and marketing of hybrid seeds, pesticides, bio-organic, and other commodities. They have completed several projects across India and delivered quality and timely work. It has a registered office in Nashik and a corporate office in New Delhi. Its website is nirmanagri.com. The company’s promoter is Pranav Kailas Bagal, who holds 66.05% of the shareholding. They were the first company in India to introduce hybrid seeds for sunflower and grain sorghum.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Sep 2023 | Dec 2023 |
|---|---|---|---|
| Net Sales | 0 | 13 | 19 |
| Other Income | 0 | 0 | 0 |
| Total Income | 0 | 13 | 19 |
| Total Expenditure | 0 | 11 | 16 |
| Operating Profit | 0 | 2 | 3 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 0 | 2 | 3 |
| Provision for Tax | 0 | 0 | 0 |
| Profit After Tax | 0 | 2 | 3 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 2 | 3 |
| Adjusted Earnings Per Share | 0 | 3.5 | 5.3 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|
| Net Sales | 4 | 13 | 29 | 32 |
| Other Income | 0 | 0 | 0 | 0 |
| Total Income | 4 | 13 | 29 | 32 |
| Total Expenditure | 4 | 10 | 24 | 27 |
| Operating Profit | 0 | 3 | 4 | 5 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 3 | 4 | 5 |
| Provision for Tax | 0 | 1 | 0 | 0 |
| Profit After Tax | 0 | 3 | 4 | 5 |
| Adjustments | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 3 | 4 | 5 |
| Adjusted Earnings Per Share | 0.2 | 10 | 6.7 | 8.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 123% | 0% | 0% | 0% |
| Operating Profit CAGR | 33% | 0% | 0% | 0% |
| PAT CAGR | 33% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 135% | NA% | NA% | NA% |
| ROE Average | 27% | 100% | 100% | 100% |
| ROCE Average | 27% | 56% | 56% | 56% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Shareholder's Funds | 0 | 3 | 27 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 |
| Other Non-Current Liabilities | 0 | -0 | -0 |
| Total Current Liabilities | 1 | 2 | 2 |
| Total Liabilities | 2 | 6 | 30 |
| Fixed Assets | 0 | 0 | 1 |
| Other Non-Current Assets | 0 | 0 | 20 |
| Total Current Assets | 2 | 6 | 9 |
| Total Assets | 2 | 6 | 30 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 1 |
| Cash Flow from Operating Activities | -0 | 0 | 0 |
| Cash Flow from Investing Activities | 0 | -0 | -21 |
| Cash Flow from Financing Activities | 1 | 0 | 20 |
| Net Cash Inflow / Outflow | 1 | 0 | -1 |
| Closing Cash & Cash Equivalent | 1 | 1 | 0 |
| # | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|
| Earnings Per Share (Rs) | 0.21 | 10 | 6.72 |
| CEPS(Rs) | 0.21 | 10.01 | 6.87 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0.25 | 10.33 | 45.22 |
| Core EBITDA Margin(%) | 1.94 | 25.39 | 15.25 |
| EBIT Margin(%) | 1.94 | 25.37 | 14.93 |
| Pre Tax Margin(%) | 1.93 | 25.36 | 14.88 |
| PAT Margin (%) | 1.43 | 18.98 | 14 |
| Cash Profit Margin (%) | 1.43 | 18.99 | 14.32 |
| ROA(%) | 3.33 | 67.38 | 22.38 |
| ROE(%) | 84.54 | 189.03 | 27.06 |
| ROCE(%) | 7 | 133.26 | 26.6 |
| Receivable days | 58.69 | 65.5 | 52.86 |
| Inventory Days | 19.21 | 11.44 | 34.05 |
| Payable days | 39.43 | 26.33 | 11.09 |
| PER(x) | 0 | 0 | 13.61 |
| Price/Book(x) | 0 | 0 | 2.02 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.07 | 0.04 | 1.94 |
| EV/Core EBITDA(x) | 3.61 | 0.15 | 12.72 |
| Net Sales Growth(%) | 0 | 252.92 | 112.08 |
| EBIT Growth(%) | 0 | 4524.86 | 24.83 |
| PAT Growth(%) | 0 | 4580.44 | 56.45 |
| EPS Growth(%) | 0 | 4580.45 | -32.81 |
| Debt/Equity(x) | 15.33 | 0.54 | 0.04 |
| Current Ratio(x) | 2.81 | 2.82 | 4.24 |
| Quick Ratio(x) | 2.46 | 2.5 | 2.05 |
| Interest Cover(x) | 740 | 3013.74 | 297.22 |
| Total Debt/Mcap(x) | 0 | 0 | 0.02 |
| # | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 65.59 | 66.05 | 66.05 | 66.05 |
| FII | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 |
| Public | 34.41 | 33.95 | 33.95 | 33.95 |
| Others | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter | 0.39 | 0.39 | 0.39 | 0.39 |
| FII | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 |
| Public | 0.21 | 0.2 | 0.2 | 0.2 |
| Others | 0 | 0 | 0 | 0 |
| Total | 0.6 | 0.6 | 0.6 | 0.6 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
